Kirk K Calhoun's Net Worth

$48.5 Thousand

Estimate Recalculated Jul 2, 2024 06:20PM EST

Who is Kirk K Calhoun?

Kirk K Calhoun does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Abraxis BioScience, Inc., Abraxis BioScience, Inc., Adams Respiratory Therapeutics, Inc., Ryerson Holding Corp, REPLIDYNE INC, PLx Pharma Inc., NantHealth, Inc., RESPONSE GENETICS INC, and MYOGEN INC.

SEC CIK

Kirk K Calhoun's CIK is 0001203721

Past Insider Trading and Trends

2007 was Kirk K Calhoun's most active year for acquiring shares with 13 total transactions. Kirk K Calhoun's most active month to acquire stocks was the month of October. 2010 was Kirk K Calhoun's most active year for disposing of shares, totalling 8 transactions. Kirk K Calhoun's most active month to dispose stocks was the month of September. 2006 saw Kirk K Calhoun paying a total of $200,700.00 for 25,273 shares, this is the most they've acquired in one year. In 2010 Kirk K Calhoun cashed out on 36,439 shares for a total of $919,296.63, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Abraxis BioScience, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
10K
$20.07
$200,700.00
10K
Aug 1
Form 4
—
0
—
—
0
Jul 21
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Dec 13
No matching records found

Abraxis BioScience, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 15
Form 4
—
0
—
—
0
Dec 10
Form 4
—
0
—
—
0
Nov 28
Form 3
—
0
—
—
0
No matching records found

Adams Respiratory Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.18K
$60.00
-$191,040.00
0
Jan 29
Form 4
+7.06%
210
—
—
3.18K
Jan 2
Form 4
—
0
—
—
0
Dec 14
Form 4
+12.18%
323
—
—
2.97K
Oct 1
Form 4
+13.53%
316
—
—
2.65K
Jul 2
Form 4
+19.07%
374
—
—
2.33K
Apr 2
Form 4
+18.06%
300
—
—
1.96K
Jan 3
Form 4
—
0
—
—
0
Dec 15
Form 4
+27.28%
356
—
—
1.66K
Oct 2
Form 4
+29.08%
294
—
—
1.3K
Jul 13
Form 4
+45.26%
315
—
—
1.01K
Apr 1
Form 4
+79.38%
308
—
—
696
Jan 1
Form 4
—
0
—
—
0
Dec 16
Form 4
∞
388
—
—
388
Oct 3
Form 3
—
0
—
—
0
No matching records found

Ryerson Holding Corp (RYI) Snapshot price: $33.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+34.12%
448
—
—
1.76K
Jul 1
Form 4
+24.81%
261
—
—
1.31K
Apr 1
Form 4
+31.50%
252
—
—
1.05K
Jan 12
Form 4
+60.00%
300
—
—
800
Oct 2
Form 4
∞
500
$11.00
$5,500.00
500
Aug 13
Form 3
—
0
—
—
0
No matching records found

REPLIDYNE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 10
Form 3
—
0
—
—
0
No matching records found